tiprankstipranks

Schrodinger price target lowered to $45 from $50 at Piper Sandler

Piper Sandler lowered the firm’s price target on Schrodinger (SDGR) to $45 from $50 and keeps an Overweight rating on the shares following quarterly results. The firm notes Schrodinger reiterated that it expects to report initial clinical data from 3 programs in 2025. Specifically, it refined guidance for SGR-1505, now expecting to report data in Q2 2025.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue